Cardinal Health, Inc. (CAH)
 NYSE: CAH · Real-Time Price · USD
 190.22
 -0.55 (-0.29%)
  At close: Nov 3, 2025, 4:00 PM EST
190.45
 +0.23 (0.12%)
  After-hours: Nov 3, 2025, 5:19 PM EST
Cardinal Health Market Cap
Cardinal Health has a market cap or net worth of $45.2 billion as of November 3, 2025. Its market cap has increased by 64.68% in one year.
Market Cap 
 45.20B
Enterprise Value 
 49.63B
1-Year Change 
 64.68%
Ranking 
 Category 
 Stock Price 
$190.22
Market Cap Chart
Since December 1, 1998, Cardinal Health's market cap has increased from $13.56B to $45.20B, an increase of 233.26%. That is a compound annual growth rate of 4.57%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 31, 2025 | 45.33B | 58.36% | 
| Dec 31, 2024 | 28.62B | 15.21% | 
| Dec 29, 2023 | 24.84B | 23.29% | 
| Dec 30, 2022 | 20.15B | 38.88% | 
| Dec 31, 2021 | 14.51B | -7.68% | 
| Dec 31, 2020 | 15.72B | 6.23% | 
| Dec 31, 2019 | 14.79B | 11.33% | 
| Dec 31, 2018 | 13.29B | -31.06% | 
| Dec 29, 2017 | 19.28B | -16.32% | 
| Dec 30, 2016 | 23.04B | -21.56% | 
| Dec 31, 2015 | 29.37B | 9.92% | 
| Dec 31, 2014 | 26.72B | 17.11% | 
| Dec 31, 2013 | 22.81B | 63.05% | 
| Dec 31, 2012 | 13.99B | -0.28% | 
| Dec 30, 2011 | 14.03B | 4.95% | 
| Dec 31, 2010 | 13.37B | 14.33% | 
| Dec 31, 2009 | 11.69B | -5.67% | 
| Dec 31, 2008 | 12.40B | -40.63% | 
| Dec 31, 2007 | 20.88B | -19.98% | 
| Dec 29, 2006 | 26.09B | -11.36% | 
| Dec 30, 2005 | 29.44B | 17.18% | 
| Dec 31, 2004 | 25.13B | -5.11% | 
| Dec 31, 2003 | 26.48B | 1.10% | 
| Dec 31, 2002 | 26.19B | -10.16% | 
| Dec 31, 2001 | 29.15B | 4.84% | 
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Eli Lilly and Company | 793.50B | 
| Johnson & Johnson | 452.95B | 
| AbbVie | 377.92B | 
| UnitedHealth Group | 299.33B | 
| AstraZeneca | 253.98B | 
| Novartis AG | 237.13B | 
| Novo Nordisk | 216.87B | 
| Abbott Laboratories | 213.72B |